National Center for Advancing Translational Sciences; Notice of Closed Meeting, 22049 [2023-07656]

Download as PDF Federal Register / Vol. 88, No. 70 / Wednesday, April 12, 2023 / Notices 22049 TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1—Continued 21 CFR section; activity Total ..................................................................... 1 There Number of respondents Number of disclosures per respondent Total annual disclosures Average burden per disclosure ........................ .......................... ........................ .............................. 1,030,270 are no capital costs or operating and maintenance costs associated with this collection of information. These estimates reflect our continued experience with the information collection. We have made nominal adjustments to reflect the addition of burden associated with gluten and certain bottled or otherwise packaged beer; petition submissions received since our last evaluation of the information collection; and informal communications with industry regarding food product labeling. Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Blvd., Suite 101, Bethesda, MD 20892, 301–827–4905, brownnac@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: April 7, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023–07683 Filed 4–11–23; 8:45 am] Dated: April 7, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4164–01–P [FR Doc. 2023–07656 Filed 4–11–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. ddrumheller on DSK120RN23PROD with NOTICES1 Total hours Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; NCATS CTSA Training Grants Review Meeting. Date: May 17, 2023. Time: 9:30 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Office of Grants Management and Scientific Review National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Suite 1001 Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nakia C. Brown, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National VerDate Sep<11>2014 19:25 Apr 11, 2023 Jkt 259001 Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute) AGENCY: National Institutes of Health, HHS. ACTION: Notice. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide an opportunity for public comment on proposed data collection projects, the National Institutes of Health, National Cancer Institute (NCI) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. DATES: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Joanne Demchok, Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, 9609 Medical Center Drive, Rockville, Md. 20892 or call non-tollfree number 240–276–5959 or Email SUMMARY: PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 your request, including your address to: peterjo@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires: written comments and/or suggestions from the public, and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimizes the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Proposed Collection Title: Specimen Resource Locator (NCI), 0925–0703: Expiration Date 11/30/2023, EXTENSION, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The availability of specimens and associated data is critical to increase our knowledge of cancer biology and to translate important research discoveries into clinical applications. The development of molecular technologies in cancer patients with defined molecular abnormalities advances the identification and development of clinically useful biomarkers and diagnostic assays that guide treatment. The discovery and validation of cancer prevention markers require researchers’ access to quality clinical biospecimens. In response to this need, NCI’s Cancer Diagnosis Program developed, and is expanding, a searchable database: Specimen Resource Locator (SRL) https:// specimens.cancer.gov/tissue/ default.htm. The SRL allows scientists in the research community and the NCI E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 88, Number 70 (Wednesday, April 12, 2023)]
[Notices]
[Page 22049]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07656]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; NCATS CTSA Training Grants Review 
Meeting.
    Date: May 17, 2023.
    Time: 9:30 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Office of Grants Management and Scientific Review 
National Center for Advancing Translational Sciences, National 
Institutes of Health, 6701 Democracy Boulevard, Suite 1001 Bethesda, 
MD 20892 (Virtual Meeting).
    Contact Person: Nakia C. Brown, Ph.D., Scientific Review 
Officer, Office of Grants Management and Scientific Review, National 
Center for Advancing Translational Sciences, National Institutes of 
Health, 6701 Democracy Blvd., Suite 101, Bethesda, MD 20892, 301-
827-4905, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: April 7, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07656 Filed 4-11-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.